Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-01-03
1999-02-02
Shah, Mukund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514396, 514263, 544242, 5483001, 5483111, A61K 31505, C07D23902
Patent
active
058665765
ABSTRACT:
Disclosed are enantiomers, diastereomers, salts, solvates, hydrates and mixtures thereof, of formula I: ##STR1## The core moiety is a monocyclic ring structure having five to six ring atoms and two nitrogen atoms at the 1 and 3 positions, n is an integer from 4 to 16, R.sub.1 and R.sub.2 are hydrogen, halogen or C.sub.1-12 alkyl or alkenyl, and (CH.sub.2).sub.n may be optionally substituted by a hydroxyl, halogen, oxygen, a C.sub.1-4 alkyl group or a dimethylamino group. The compounds and pharmaceutical composition thereof are useful in methods for treating an individual having a disease or treatment-induced toxicity mediated through a second messenger.
REFERENCES:
patent: 3422107 (1969-01-01), Mohler et al.
patent: 3737433 (1973-06-01), Mohler et al.
patent: 4515795 (1985-05-01), Hinze et al.
patent: 4576947 (1986-03-01), Hinze et al.
patent: 4636507 (1987-01-01), Kreutzer et al.
patent: 4833146 (1989-05-01), Gebert et al.
patent: 4965271 (1990-10-01), Mandell et al.
patent: 5039666 (1991-08-01), Novick et al.
patent: 5096906 (1992-03-01), Mandell et al.
patent: 5158967 (1992-10-01), Hall
patent: B13737433 (1987-03-01), Mohler et al.
Akhmedov et al., Chemical Abstract, No. 99:158152e, "Study of the Reaction of Unsaturated Chlorine-Containing Epoxy Compounds with Secondary Amines," 1982.
Bianco et al., Blood, 76: Supplement 1 (522), p. 133a, "Pentoxifylline (PTX) and GM-CSF Decrease Tumor Necrosis Factor-Alpha (TNF-.alpha.) Levels in Patients Undergoing Allogeneic Bone Marrow Transplantation (BMT)", 1991.
Davis et al., Applied Environment Microbial., 48:2, pp. 327-331, "Microbial Models of Mammalian Metabolism: Microbial Reduction and Oxidation of Pentoxifylline", Aug. 1984.
Jakubowski et al., J. Org. Chem., 47, pp. 1221-1228, Total Syntheses of (.+-.)-Cerulenin, (.+-.)-Tetrahydrocerulenin, and Related Compounds, 1982.
Klein J. Peter
Kumar Anil
Leigh Alistair
Michnick John
Underiner Gail
Cell Therapeutics Inc.
Shah Mukund J.
Sripada Pavanaram K
LandOfFree
Epoxide-containing compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Epoxide-containing compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Epoxide-containing compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1117721